Krankenhaushygiene up2date, Table of Contents Krankenhaushygiene up2date 2014; 09(01): 21-38DOI: 10.1055/s-0034-1364961 Nosokomiale Infektionen © Georg Thieme Verlag KG Stuttgart · New YorkInfektionsprävention im Blutspendewesen Authors Gregor Caspari Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Full Text References Weiterführende Literatur Transfusionsgesetz (TFG). www.gesetze-im-internet.de 1 Bundesärztekammer. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Zweite Richtlinienanpassung 2010. http://www.bundesaerztekammer.de/downloads/rilihaemotherapie2010.pdf Übersichten 2 Caspari G, Gerlich WH. Durch Blut übertragbare Infektionskrankheiten. In: Kiefel V, Hrsg. Transfusionsmedizin. 4. Aufl. Berlin: Springer Verlag; 2010: 529-574 3 De Mendoza C, Altisent C, Aznar JA et al. Emerging viral infections – a potential threat for the blood supply in the 21st century. AIDS Rev 2012; 14: 279-289 4 Dodd RY. Emerging pathogens and their implications for the blood supply and transfusion transmitted infections. Br J Haematol 2012; 159: 135-142 doi: 10.1111/bjh.12031. Epub 28. August 2012 5 Horvath KA, Acker MA, Chang H et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 2013; 95: 2194-2201 doi: 10.1016/j.athoracsur.2012.11.078. Epub 3. Mai 2013 6 Kleinman S, King MR, Busch MP et al. National Heart Lung Blood Institute Retrovirus Epidemiology Donor Study; Retrovirus Epidemiology Donor Study-IIThe National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II). Twenty years of research to advance blood product safety and availability. Transfus Med Rev 2012; 26: 281-304 doi: 10.1016/j.tmrv.2012.04.004. Epub 24. Mai 2012 7 Lürmann A. Eine Icterusepidemie. Berliner Klinische Wochenschrift 1885; 22: 20-23 8 Offergeld R, Ritter S, Hamouda O. HIV-, HCV-, HBV- und Syphilissurveillance unter Blutspendern in Deutschland (2008–2010). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012; 55: 907-913 doi: 10.1007/s00103-012-1516-1 9 Zou S, Stramer SL, Dodd RY. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev 2012; 26: 119-128. doi: 10.1016/j.tmrv.2011.07.007. Epub 25. August 2011 doi: 10.1016/j.tmrv.2011.07.007. Epub 25. August 2011 Virale Infektionen 10 Allain JP, Mihaljevic I, Gonzalez-Fraile MI et al. Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion 2013; 53: 1405-1415 doi: 10.1111/trf.12096. Epub 30. Januar 2013 11 Caspari G. Hepatitis E Virus: Übertragungen auch in Europa. Der Mikrobiologe 2009; 19: 4-8 12 Fatal West Nile Virus Infection after probable transfusion-associated transmission – Colorado 2012. MMWR 2013; 62: 622-624 13 Coppola N, Loquercio G, Tonziello G et al. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J Clin Virol 2013; 58: 315-317 doi: 10.1016/j.jcv.2013.06.020. Epub 12. Juli 2013 14 Hewitt PE, Davison K, Howell DR et al. Human T-lymphotropic virus lookback in NHS Blood and Transplant (England) reveals the efficacy of leukoreduction. Transfusion 2013; doi: 10.1111/trf.12105. [Epub ahead of print] 15 Juhl D, Baylis SA, Blümel J et al. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion 2013; doi: 10.1111/trf.12121. [Epub ahead of print] 16 O’Brien SF, Goldman M, Scalia V et al. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med 2013; doi: 10.1111/tme.12057. [Epub ahead of print] 17 Raimondo G, Caccamo G, Filomia R et al. Occult HBV infection. Semin Immunopathol 2013; 35: 39-52 18 Seed CR, Kiely P. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening. Vox Sang 2013; . doi: 10.1111/vox.12060. [Epub ahead of print] 19 Soucie JM, De Staercke C, Monahan PE US Hemophilia Treatment Center Network et al. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion 2013; 53: 1217-1225 doi: 10.1111/j.1537-2995.2012.03907.x. Epub 24. September 2012 20 Vermund SH, Leigh-Brown AJ. The HIV epidemic: high income countries. Cold Spring Harbor Perspectives in Medicine 2012; 2: a997195 21 Ziemann M, Heuft HG, Frank K et al. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections. Transfusion 2013; 53: 1088-1094 doi: 10.1111/trf.12074. Epub 16. Januar 2013 Infektionen durch Bakterien, Einzeller und Helminthen (Parasiten) 22 Benjamin RJ, Stramer SL, Leiby DA et al. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion 2012; 52: 1913-1921 quiz 1912. doi: 10.1111/j.1537-2995.2011.03554.x. Epub 10. Februar 2012 23 Kessler DA, Shi PA, Avecilla ST et al. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion 2013; 53: 1083-1087 doi: 10.1111/j.1537-2995.2012.03856.x. Epub 15. August 2012 24 Kumar P, Marshall BC, deBlois G et al. Real time PCR diagnosis of Plasmodium vivax among blood donors. Malaria Journal 2012; 11, 345-350 25 Kumar P, Marshall BC, deBlois G et al. A cluster of transfusion-associated babesiosis in extremely low birthweight premature infants. J Perinatol 2012; 32: 731-733 doi: 10.1038/jp.2012.33 26 Salamanca-Dejour D, Blanchet D, Aznar C et al. La maladie de Chagas (ou trypanosomose américaine) en France. Med Mal Infect 2012; 42: 344-348 doi: 10.1016/j.medmal.2011.01.006. Epub 14. Mai 2012 Infektionen durch Prionen 27 Barrenetxea G. Iatrogenic prion diseases in humans: an update. Eur J Obstet Gynecol Reprod Biol 2012; 165: 165-169 doi: 10.1016/j.ejogrb.2012.08.014. Epub 28. August 2012 28 Bishop MT, Diack AB, Ritchie DL et al. Prion infectivity in the spleen of am PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain 2013; 136: 1139-1145 29 Martin M, Trouvin JH. Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15years. Transfus Clin Biol 2013; pii: S1246-7820(13)00482-5. doi: 10.1016/j.tracli.2013.06.001. [Epub ahead of print] 30 Caspari G, Gerlich WH, Kiefel V et al. Pathogen inactivation of cellular blood products – still plenty of reason to be careful. Transfusion Medicine and Hemotherapy 2005; 32: 258-260 Pathogeninaktivierung 31 O’Brien SF, Fan W, Xi G et al. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience. Vox Sang 2010; 98: 138-144 doi: 10.1111/j.1423-0410.2009.01236.x. Epub 14 September 2009 Spenderauswahl 32 Sümnig A, Konerding U, Kohlmann T et al. Factors influencing confidential unit exclusions in blood donors. Vox Sang 2010; 98: e231-240 doi: 10.1111/j.1423-0410.2009.01250.x. Epub 18. September 2009
